Physician profile
Murat Sen
NPI 1811957087
$2,128.46
in general payments reported to CMS, 2019-2025
18 companies · $1,083 in 2025
The $1,083 reported for 2025 was more than what 82% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.23 · 2022: $112 · 2023: $201 · 2024: $721 · 2025: $1,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $935.30 | 2022-2025 | Puraply Wound Matrix, Nushield, Apligraf |
| Abbvie INC. | $232.48 | 2022-2025 | |
| Corcept Therapeutics | $172.23 | 2023-2024 | Korlym |
| Abbott Laboratories | $170.30 | 2025 | Allure Quadra, Cardiomems, Gallant |
| Biowound Solutions, INC. | $138.54 | 2025 | Bio-Connekt |
| Merck Sharp & Dohme LLC | $108.44 | 2022-2024 | Verquvo, Belsomra, Vaxelis |
| Convatec INC. | $62.66 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.20 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.84 | 2023 | Glassia |
| Glaxosmithkline, LLC. | $36.73 | 2024 | Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $32.24 | 2024 | Airsupra |
| Sandoz INC. | $29.60 | 2025 | |
| Edwards Lifesciences Corporation | $27.76 | 2024 | |
| Sanofi Pasteur INC. | $23.73 | 2023 | |
| Reprise Biomedical, INC. | $17.09 | 2025 | Miro3d |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.73 | 2024 | |
| Avanos Medical | $13.36 | 2024 | Trivisc Sodium Hyaluronate |
| Mylan Specialty L.P. | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murat Sen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.